Shopping Cart
- Remove All
- Your shopping cart is currently empty
Vandetanib Fumarate is an orally available tyrosine kinase inhibitor. Vandetanib Fumarate works by blocking RET (REarranged during Transfection), vascular endothelial growth factor receptor (VEGFR-2, VEGFR-3), and epidermal growth factor receptor and to a lesser extent VEGFR-1, which are important targets in thyroid cancer (TC).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,670 | 1-2 weeks | |
50 mg | $2,180 | 1-2 weeks | |
100 mg | $2,800 | 1-2 weeks |
Description | Vandetanib Fumarate is an orally available tyrosine kinase inhibitor. Vandetanib Fumarate works by blocking RET (REarranged during Transfection), vascular endothelial growth factor receptor (VEGFR-2, VEGFR-3), and epidermal growth factor receptor and to a |
Alias | ZD 6474, Zactima, Vandetanib, HSDB 8198, Caprelsa |
Molecular Weight | 591.43 |
Formula | C26H28BrFN4O6 |
Cas No. | 338992-00-0 |
Relative Density. | 1.406 g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.